Since the second half of the twentieth century, intracranial electroencephalography (iEEG),
including both electrocorticography (ECoG) and stereo-electroencephalography (sEEG) …

BACKGROUND: Neuromodulation-based treatments have become increasingly important in
epilepsy treatment. Most patients with epilepsy treated with neuromodulation do not achieve …

One-third of persons with epilepsy have seizures despite appropriate medical therapy. Drug
resistant epilepsy (DRE) is associated with neurocognitive and psychological decline, poor …

Findings from randomised controlled trials, along with more than 100 case series and
observational studies, support the efficacy and safety of resective surgery and, more …

Epilepsy is a debilitating neurological disorder affecting approximately 1% of the world's
population. Drug-resistant focal epilepsies are potentially surgically remediable. Although …

While temporal lobe epilepsy (TLE) is the most common epilepsy syndrome in adults,
seizures in children are more often extratemporal in origin. Extra–temporal lobe epilepsy …

Patients with drug‐resistant epilepsy (DRE) rarely achieve seizure freedom with medical
therapy alone. Despite being safe and effective for select patients with DRE, epilepsy …

Epilepsy is one of the most common neurologic disorders in the world. While anti-epileptic
drugs (AEDs) are the mainstay of treatment in most cases, as many as one-third of patients …

Background and Objectives Patients with drug-resistant epilepsy (DRE) may benefit from
specialized testing and treatments to better control seizures and improve quality of life. Most …

Temporal lobe epilepsy (TLE) is the most common form of epilepsy in adults and is
responsible for 15%–20% of epilepsy cases in children. Class I evidence strongly supports …